Related Experiment Video
Updated: Feb 18, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
[Diagnostics of Wilson's disease].
1Neurologie, SRO AG Langenthal, St. Urbanstraße 67, 4900, Langenthal, Schweiz. w.hermann@sro.ch.
Early diagnosis and treatment of Wilson's disease, a rare genetic liver disorder, are crucial for a favorable prognosis. Prompt biochemical and genetic testing aids in identifying this treatable condition for timely intervention.
Area of Science:
- Genetics
- Metabolic Disorders
- Neurology
Background:
- Wilson's disease is a rare, inherited metabolic disorder.
- It involves copper accumulation, leading to liver and neurological damage.
- Early diagnosis and treatment are vital for a positive outcome.
Purpose of the Study:
- To emphasize the importance of early diagnosis and reliable testing for Wilson's disease.
- To outline the diagnostic work-up and available investigation methods.
- To stress the necessity of immediate treatment upon diagnosis.
Main Methods:
- Diagnostic work-up initiated for unexplained liver disease or extrapyramidal symptoms.
- Biochemical and genetic examinations for early detection.
- Ancillary tests including imaging (MRI, SPECT, PET) and functional assessments.
Main Results:
- Wilson's disease presents with diverse symptoms, often between ages 5 and 45, but can occur earlier or later.
- While some tests are unspecific, they aid in assessing organ damage and monitoring disease progression.
- Prompt initiation of therapy is essential once a diagnosis is confirmed.
Conclusions:
- Knowledge and timely diagnosis of Wilson's disease are indispensable.
- Biochemical and genetic testing are key for early identification.
- Adequate treatment following confirmed diagnosis leads to a favorable prognosis.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Therapeutic Drug Monitoring: Drug Analysis Methods
Serum Laboratory Studies, Stool Test, Breath Test